Inventor

O'CONNOR JASON

US49 patents

⚠️ This page may combine multiple inventors who share the name “O'CONNOR JASON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

O'CONNOR JASON

INSULET CORP

Wearable automated medication delivery system

Automated drug delivery system

Techniques enabling adaptation of parameters in aid systems by user input

Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith

User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system

Drug delivery insertion apparatuses and system

Drug delivery system with sensor having optimized communication and infusion site

Techniques and devices providing adaptivity and personalization in diabetes treatment

Initial total daily insulin setting for user onboarding

Safety constraints for a control algorithm based drug delivery system

Compensation for missing readings from a glucose monitor in an automated insulin delivery system

Activity mode for artificial pancreas system

Compensation for missing readings from a glucose monitor in an automated insulin delivery system

Wearable automated medication delivery system

Automated insulin delivery system using pramlintide

Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system

User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system

Optimizing embedded formulations for drug delivery

Adaptive update of automatic insulin delivery (AID) control parameters

Techniques to reduce risk of occlusions in drug delivery systems

Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system

Adaptable asymmetric medicament cost component in a control system for medicament delivery

Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns

Blood glucose rate of change modulation of meal and correction insulin bolus quantity

Wearable automated medication delivery system

Fluid delivery device, transcutaneous access tool and insertion mechanism for use therewith

Techniques to reduce risk of occlusions in drug delivery systems

Event detection for drug delivery system

Optimizing embedded formulations for drug delivery

Scheduling of medicament bolus deliveries by a medicament delivery device at future dates and times with a computing device

Onboarding and total daily insulin adaptivity

Initial total daily insulin setting for user onboarding

Initial total daily insulin setting for user onboarding

Activity mode for artificial pancreas system

Early meal detection and calorie intake detection

Safety constraints for a control algorithm based drug delivery system

Safety constraints for a control algorithm based drug delivery system

Early meal detection and calorie intake detection

Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk

Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk

Wearable micro-dosing drug delivery device

Techniques for determining automated insulin delivery dosages

Adjusting medicament delivery parameters in an open loop medicament delivery mode

Open-loop insulin delivery basal parameters based on insulin delivery records

Prediction of meal and/or exercise events based on persistent residuals

Fluid flow regulation arrangements for drug delivery devices

Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions

Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device

HEAT TRACE LTD

Heating cable